Cancer Control · 2022 · 16 citations · 33 references
MedicineCancer BiologyOncologyPrecision MedicinePrecision OncologyTheranosticsCancer Precision MedicineCancer ProteomicsLung CancerMolecular Tumor ProfilingPersonalized Cancer TherapyPersonalized Treatment PlanningCell Line-derived Xenograft ModelsPersonalized Cancer MedicinePersonalized Cancer TreatmentPersonalized Therapy OptimizationPrecision Medicine ApplicationsPrecision Oncology ApplicationsPrecision Oncology Target DiscoveryTumor Profiling
Precision medicine for lung cancer theranostics is an advanced model combining prevention, diagnosis, and treatment for individual or specific population diseases to match individual patient differences. It involves collection and integration of genome, transcriptome, proteome, and metabolome features of lung cancer patients, combined with clinical characteristics. Subsequently, large data and artificial intelligence (AI) analysis have emerged to identify the most suitable therapeutic targets and personal treatment strategies for treatment of patients with lung cancer. We review the development and challenges associated with diagnosis and therapy of lung cancer from traditional technology, including immunotherapy prediction markers, liquid biopsy, surgery, and tumor immune microenvironment and patient-derived xenograft models, to AI in the era of precision medicine. AI has improved precision medicine and the predictive ability and accuracy of patient outcomes. Finally, we discuss some opportunities and challenges for lung cancer theranostics. Precision medicine in lung cancer can help us find the optimum treatment dose and time for a specific patient, which can advance the development of lung cancer therapeutics.
33
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies, Paul E. Kinahan, Hedvig Hricak · Radiology · 2015 · 8.3K citations
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
Nadia Howlader, Gonçalo Forjaz, Meghan J. Mooradian et al. · New England Journal of Medicine · 2020 · 1.7K citations · Full text
Treatable traits: toward precision medicine of chronic airway diseases
Àlvar Agustí, Elisabeth H. Bel, Mike Thomas et al. · European Respiratory Journal · 2016 · 1K citations · Full text
Medicine, Genetics, Medical Genetics +14
<i>EML4-ALK</i> Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
Jussi Koivunen, Craig H. Mermel, Kreshnik Zejnullahu et al. · Clinical Cancer Research · 2008 · 983 citations · Full text
Medicine, Oncology, Pharmacology +17